Neurocrine Biosciences Chief Scientific Officer Jude Onyia sold $1.76 million in company stock. The transaction involved shares of the pharmaceutical company.
Insider selling by a high-ranking executive can sometimes signal a lack of confidence in the company's future prospects, potentially impacting investor sentiment.
Neurocrine Biosciences Chief Scientific Officer Jude Onyia sold $1.76 million in company stock. The transaction involved shares of the pharmaceutical company.
Pick the topics you care about. Get only what matters, on your cadence.
Trading stocks, CFDs, spread betting, futures, and options involves a high level of risk and may not be suitable for all investors. Prices can move rapidly, and losses can occur quickly and exceed your expectations.
